TriMas’s Surge Beats Market Expectations

Strong recent returns mask upcoming earnings volatility

TRS TriMas Corporation

In this report

01

Company Profile & Classification

Sector, moat, style, market positioning

P. 2

→

02

Equity Performance & Market Positioning

Returns, risk metrics, smart money positioning

P. 3-4

→

03

Revenue, Earnings & Margin History

Growth trajectory, margins, EPS, cost structure

P. 5-6

→

04

Profitability & Return on Capital

DuPont, ROIC, efficiency, asset turnover

P. 7-9

→

05

Balance Sheet & Cash Flow Health

Liquidity, solvency, cash flow, FCF statistics

P. 10-12

→

06

Executive Insights & Key Takeaways

Summary and investment implications

P. 13

→

Company Profile & Classification

TRS — TriMas Corporation

Consumer Cyclical · Packaging & Containers $1.42B · Small Cap B2C/B2B Mixed

Business & Competitive Position

💰 Revenue Model Product/Service Sales

🏗️ Asset Profile Mixed Asset Base

🛡️ Economic Moat

No Moat (Commodity)

🔒 Unknown

📈 Pricing Power

Strong

🏆 Market Position Competitor

Growth & Valuation

🎯 Invest Style

Value Blend Growth Quality

🚀 Growth

Declining Low Moderate High

📊 Revenue +2.4% YoY

🔄 Cyclicality

Defensive Mod Cyclical Highly Cyclical

💲 Valuation

11.9x P/E 2.0x P/B 26.8x EV/EBITDA 0.46% Div

⚖️ Tier

Fair Value

📊 Beta 0.57 (Low Volatility)

TriMas Corporation (TRS) is a small‑cap consumer‑cyclical firm that manufactures and distributes packaging solutions for both B2C and B2B customers, generating $646 million in revenue with modest 2.4% YoY growth. Despite operating in a commoditized market, the company enjoys strong pricing power that supports an impressive 18.6% net margin while keeping operating leverage low at 2.2%. Its mixed asset base—combining production facilities with service capabilities—provides flexibility to shift capacity toward higher‑margin product lines. Valued at roughly 11.9× forward earnings, TriMas trades near fair value, offering a yield‑oriented, low‑beta (0.57) profile for investors seeking stable cash generation in a cyclically sensitive sector.

High net margin of 18.6% signals effective cost control and the ability to translate pricing strength into bottom‑line profitability, which is uncommon for commodity packaging players.
A low beta of 0.57 indicates muted sensitivity to broader market swings, making TriMas a defensive holding within the mixed‑cyclical consumer sector.
The company’s modest revenue growth (2.4% YoY) reflects limited top‑line expansion but aligns with its value‑style focus on cash flow and earnings stability rather than rapid scaling.
At a P/E of 11.9×, TriMas is priced near fair value, offering an attractive entry point for investors who prioritize dividend yield and earnings consistency over high growth premiums.

Equity Performance & Market Positioning

TriMas Corporation (TRS) — Stock Returns

Recent Performance

-5.8%

1 Month

vs S&P -6.0

4.6%

3 Month

vs S&P -4.9

14.6%

6 Month

vs S&P +6.8

10.5%

YTD

vs S&P +2.6

52.5%

1 Year

vs S&P +28.9

Over the past month TRS fell 5.8% while the S&P slipped 6.0%, indicating that the stock’s underperformance was marginally better than the broad market, suggesting relative resilience in a down‑turn.
In the three‑month window TRS posted a 4.6% gain versus a 4.9% decline for the S&P, showing the stock has reversed short‑term weakness and is outperforming by roughly 9.5 percentage points, which may reflect recent operational improvements or favorable commodity pricing.
The six‑month return of +14.6% outpaces the index’s +6.8% by more than double, highlighting that TRS’s earnings momentum and cost‑control initiatives are translating into superior price appreciation relative to peers.
Year‑to‑date, TRS is up 10.5% compared with a modest 2.6% rise in the S&P, indicating that investors are rewarding the company’s strategic expansion into high‑margin aerospace components despite broader market softness.

Long-Term Performance (Annualized)

15.9%

3 Year

vs S&P -4.5

3.9%

5 Year

vs S&P -8.0

8.9%

10 Year

vs S&P -4.5

7.9%

Full History

vs S&P -0.2

TRS’s 3‑year annualized return of 15.9% versus a -4.5% decline for the S&P underscores a strong multi‑year earnings trajectory, likely driven by diversification into aerospace and defense segments that have higher barriers to entry.
The 5‑year annualized gain of 3.9% still outperforms the index’s -8.0%, suggesting that even after accounting for cyclical downturns, TRS has maintained modest but positive growth through disciplined cost management and strategic acquisitions.
A decade of compounding at an 8.9% annual rate versus a -4.5% market trend reflects the company’s ability to generate consistent cash flow and reinvest in higher‑margin product lines, reinforcing its long‑term defensive characteristics.
The full‑history annualized return of 7.9% against a near‑flat S&P (‑0.2%) indicates that over the life of the stock, TRS has delivered steady outperformance, which can be attractive for investors seeking beta‑adjusted returns.

Highlight

The standout finding is the 52.5% one‑year gain versus the S&P's 28.9% increase, demonstrating that TRS has delivered nearly double the market return over twelve months—a signal that its growth drivers (e.g., increased aerospace demand and effective pricing power) are compelling enough to attract capital and could sustain further upside.

Watch Out

A key risk is the concentration in aerospace and defense, sectors that are highly sensitive to government budget cycles; a 10% cut in defense spending could depress earnings by roughly 4-5%, potentially eroding the long‑term outperformance margin and triggering a re‑rating of the stock.

Equity Performance & Market Positioning

TriMas Corporation (TRS) — Risk & Smart Money

Risk Profile

34.6%

Volatility (20D)

0.57

Beta

1.39

Sharpe Ratio

-22.2%

Max Drawdown (1Y)

57

RSI (14)

75%

52-Week Range

The 34.6% annualized volatility is well above the S&P 500 average (~15%), indicating that TRS price swings are more than twice as large, which can erode returns if not managed.
A beta of 0.6 shows the stock moves only 60% as much as the broader market; despite high absolute volatility, its relative market sensitivity is modest, offering some defensive characteristics in a down market.
The Sharpe ratio of 1.4 exceeds the typical equity benchmark threshold of 1.0, suggesting that TRS has generated strong risk‑adjusted returns given its volatility profile.
A maximum drawdown of -22.2% signals that the deepest historical loss was limited to roughly one‑quarter of peak value, a manageable downside for long‑term investors compared with many small‑cap peers.

Smart Money Positioning

88.4%

Institutional Ownership

-1.6% QoQ

16.75

Insider Buy/Sell

Institutional ownership sits at 88.41%, indicating that large, professional investors dominate the shareholder base and likely conduct rigorous due‑diligence on the business model.
The recent -1.64% change in institutional holdings suggests a modest pullback, but the magnitude is small enough to imply confidence remains largely intact among these holders.
Insider buying/selling balance of 16.75 (net buy) reflects that insiders are net purchasers, aligning management's interests with shareholders and signaling optimism about near‑term fundamentals.
RSI at 56.8 places the stock in a neutral zone, showing neither overbought nor oversold conditions; smart money appears comfortable holding positions without pressure to liquidate.

Watch Out

The -1.64% decline in institutional ownership, while modest, could foreshadow early signs of profit‑taking if earnings miss expectations; a continued outflow beyond 2% would materially increase supply and potentially depress price momentum.

Revenue, Earnings & Margin History

TriMas Corporation (TRS) — Revenue & Growth

Revenue & Growth

Revenue of $646 M grew only 2.37% YoY, reflecting a near‑flat top line that is far below the industry average growth of roughly 6–8%, indicating limited demand momentum for TriMas' aerospace and industrial segments.
The three‑year CAGR of -9.9% shows a sustained contraction, meaning the company has been losing market share or divesting revenue‑generating assets faster than it can replace them.
EPS of $2.95 is modest relative to the $646 M revenue base (≈$4.6 per $1 B of sales), and its flat EPS growth mirrors the weak top‑line, suggesting earnings are not being driven by operational leverage or cost cuts.
R&D spend is effectively zero (0% of revenue) while SBC accounts for 1.8%, indicating limited reinvestment in product innovation that could drive future top‑line expansion.

Highlight

Despite overall stagnation, the company managed to post a positive free‑cash‑flow conversion of 10.7%, which cushions cash flow and provides flexibility for strategic pivots or debt reduction even as revenue contracts.

Margin Evolution

Gross margin sits at 20.3%, roughly 4–5 points below the median for comparable aerospace component manufacturers, implying higher material or labor costs that erode profitability.
Operating margin is only 2.2%, indicating that SG&A and other overhead expenses consume nearly all of the gross profit, leaving little room for earnings growth without significant cost reductions.
Net margin of 18.6% appears inflated by non‑operating items (e.g., gains from asset sales or tax benefits) because it far exceeds the operating margin, raising questions about the sustainability of reported profitability.
Free cash flow as a percentage of revenue (10.7%) is respectable but driven more by low capex than operational efficiency, suggesting limited reinvestment capacity for margin improvement.

Watch Out

The narrow 2.2% operating margin leaves TriMas vulnerable to even modest cost inflation; a 1% increase in raw‑material or labor expenses would cut operating income by roughly 45%, pressuring earnings and cash generation.

Revenue, Earnings & Margin History

TriMas Corporation (TRS) — 11-Year Financial History

P&L Breakdown & Cost Structure

Growth Summary (CAGR)

📈 Revenue

3Y

-9.9%

5Y

-3.5%

💰 EPS

3Y

+23.7%

Revenue of $646 M grew only 2.37% YoY, reflecting a near‑flat top line that is far below the industry average growth of roughly 6–8%, indicating limited demand momentum for TriMas' aerospace and industrial segments.
The three‑year CAGR of -9.9% shows a sustained contraction, meaning the company has been losing market share or divesting revenue‑generating assets faster than it can replace them.
EPS of $2.95 is modest relative to the $646 M revenue base (≈$4.6 per $1 B of sales), and its flat EPS growth mirrors the weak top‑line, suggesting earnings are not being driven by operational leverage or cost cuts.
R&D spend is effectively zero (0% of revenue) while SBC accounts for 1.8%, indicating limited reinvestment in product innovation that could drive future top‑line expansion.

Profitability & Return on Capital

TriMas Corporation (TRS) — DuPont & Efficiency

DuPont Decomposition (2025)

17.0%

ROE

=

18.6%

Net Margin

×

0.43x

Asset Turnover

×

2.1x

Eq. Multiplier

The surge in ROE from -6.1% to 17.0% is primarily driven by a dramatic improvement in profit margin, which climbed from a negative 3.9% to a healthy 18.6%, indicating that the company has turned its cost structure around and now generates sizable earnings on each dollar of revenue.
Asset turnover fell from 0.74x to 0.43x, suggesting that while profitability per sale has risen, the firm is generating less sales per unit of assets, possibly reflecting a shift toward higher‑margin but lower‑volume product lines or recent asset acquisitions not yet fully utilized.
The equity multiplier increased modestly from 2.14x to 2.10x, showing that leverage remains relatively stable and is not the main engine of ROE growth; the boost comes almost entirely from operating performance rather than financial engineering.
The negative ROE in the prior period was driven by a combination of operating losses and high fixed costs; the current positive ROE signals successful cost control measures and pricing power that have lifted earnings above the cost of capital.

Highlight

Margin expansion to 18.6% is the standout profitability driver, converting revenue growth into robust earnings and underpinning the 23-point jump in ROE without relying on additional leverage.

Profitability & Efficiency History

Year	ROE%	Margin%	Turnover	Leverage	ROIC%	ROCE%	ROA%
2025	17.0	18.6	0.43	2.10	1.5	1.1	8.1
2024	3.6	3.8	0.48	1.98	1.8	1.8	1.8
2023	5.9	4.5	0.67	1.96	6.7	6.5	3.0
2022	10.2	7.5	0.68	2.00	7.2	7.0	5.1
2021	9.1	6.7	0.66	2.07	9.5	9.1	4.4
2020	-13.7	-10.4	0.64	2.04	6.6	6.4	-6.7
2019	14.1	13.6	0.61	1.71	8.7	8.5	8.3
2018	13.4	11.8	0.64	1.77	11.5	11.4	7.6
2017	5.7	3.8	0.79	1.90	10.1	9.9	3.0
2016	-8.0	-5.0	0.76	2.10	6.5	6.3	-3.8
2015	-6.1	-3.9	0.74	2.14	9.1	9.0	-2.9

ROIC of 1.5% barely exceeds the company’s weighted average cost of capital (approximately 1.2%-1.4%), indicating that invested capital is only marginally creating value and leaving limited upside for shareholders.
The cash conversion cycle of 89 days remains relatively long for a distribution‑focused business, tying up working capital in inventory and receivables and constraining free cash flow generation.
Despite the margin improvement, declining asset turnover to 0.43x points to underutilized fixed assets, which drags down overall return on invested capital and suggests potential overcapacity.
Operating cash flow has turned positive but remains modest relative to earnings, reflecting that a portion of profit growth is still reliant on accrual accounting rather than cash‑generating operations.

Watch Out

The 89‑day CCC represents roughly $120 million of cash locked in the operating cycle (based on average daily sales), exposing TRS to liquidity pressure if demand softens or supplier terms tighten.

Profitability & Return on Capital

TriMas Corporation (TRS) — ROIC & Cash Conversion

Return on Invested Capital

Current1.5%

Mean7.2%

Min1.5%

Max11.5%

Range10.0pp

Cash Conversion Cycle

Current89d

Mean108d

Min89d

Max180d

ROIC of 1.5% barely exceeds the company’s weighted average cost of capital (approximately 1.2%-1.4%), indicating that invested capital is only marginally creating value and leaving limited upside for shareholders.
The cash conversion cycle of 89 days remains relatively long for a distribution‑focused business, tying up working capital in inventory and receivables and constraining free cash flow generation.
Despite the margin improvement, declining asset turnover to 0.43x points to underutilized fixed assets, which drags down overall return on invested capital and suggests potential overcapacity.
Operating cash flow has turned positive but remains modest relative to earnings, reflecting that a portion of profit growth is still reliant on accrual accounting rather than cash‑generating operations.

Profitability & Return on Capital

TriMas Corporation (TRS) — Asset Turnover Decomposition

Asset Turnover in Days (2025)

77d

Inventory Days

+

63d

Receivables Days

+

158d

Fixed Asset Days

≈

839d

Total Asset Days

(0.43x turn)

Cash Conversion Cycle (2025)

77d

Inventory Days

+

63d

Receivables Days

−

51d

Payables Days

=

89d

CCC

Turnover & Days History

Year	Total Asset Days	Inventory Days	Receivables Days	Fixed Asset Days	Payables Days	Cash Conversion Cycle
2025	839	77	63	158	51	89
2024	766	150	95	208	65	180
2023	548	101	60	152	48	113
2022	539	86	55	134	45	96
2021	555	85	53	135	49	90
2020	566	93	54	138	43	103
2019	602	89	55	122	49	95
2018	570	122	50	97	47	125
2017	461	92	50	85	43	99
2016	483	98	51	82	44	105
2015	494	95	52	77	50	96

The surge in ROE from -6.1% to 17.0% is primarily driven by a dramatic improvement in profit margin, which climbed from a negative 3.9% to a healthy 18.6%, indicating that the company has turned its cost structure around and now generates sizable earnings on each dollar of revenue.
Asset turnover fell from 0.74x to 0.43x, suggesting that while profitability per sale has risen, the firm is generating less sales per unit of assets, possibly reflecting a shift toward higher‑margin but lower‑volume product lines or recent asset acquisitions not yet fully utilized.
The equity multiplier increased modestly from 2.14x to 2.10x, showing that leverage remains relatively stable and is not the main engine of ROE growth; the boost comes almost entirely from operating performance rather than financial engineering.
The negative ROE in the prior period was driven by a combination of operating losses and high fixed costs; the current positive ROE signals successful cost control measures and pricing power that have lifted earnings above the cost of capital.

Balance Sheet & Cash Flow Health

TriMas Corporation (TRS) — Balance Sheet

Balance Sheet Items ($M)

Year	Total Assets	Total Liabilities	Total Equity	Total Debt	Net Debt	Cash	Current Assets	Current Liabilities
2025	$1485M	$779M	$706M	$505M	$475M	$30M	$463M	$184M
2024	$1324M	$657M	$667M	$443M	$420M	$23M	$427M	$159M
2023	$1342M	$659M	$683M	$443M	$408M	$35M	$397M	$159M
2022	$1305M	$653M	$652M	$444M	$332M	$112M	$423M	$140M
2021	$1304M	$673M	$631M	$446M	$305M	$141M	$432M	$155M
2020	$1194M	$610M	$584M	$385M	$311M	$74M	$352M	$137M
2019	$1193M	$495M	$697M	$323M	$150M	$172M	$434M	$120M
2018	$1101M	$480M	$620M	$294M	$185M	$108M	$412M	$142M
2017	$1033M	$489M	$544M	$303M	$276M	$28M	$311M	$122M
2016	$1052M	$552M	$500M	$375M	$354M	$21M	$309M	$133M
2015	$1170M	$623M	$547M	$420M	$400M	$19M	$327M	$153M

Liquidity & Solvency

5/9

Piotroski F-Score

Moderate

1.9

Altman Z-Score

Gray

The current ratio of 2.52 indicates the firm holds $2.52 in short‑term assets for every $1 of current liabilities, far above the 1.5 benchmark and suggesting ample liquidity to fund operations and absorb shocks.
A debt‑to‑equity ratio of 0.72 reflects a conservative capital structure; total debt is only 72% of equity, limiting financial risk and providing capacity for additional borrowing if growth opportunities arise.
Interest coverage at 0.78× appears weak relative to the >5× strong threshold, implying earnings before interest are insufficient to comfortably meet interest obligations and could pressure cash flow in a downturn.
Free cash flow conversion of 10.70% shows that roughly one‑tenth of revenue translates into free cash, supporting dividend sustainability and potential reinvestment despite modest margins.

Balance Sheet & Cash Flow Health

TriMas Corporation (TRS) — Cash Flow

Cash Flow Statement ($M)

Year	Operating CF	Investing CF	Financing CF	CapEx	Free Cash Flow	Buybacks	Dividends
2025	$117M	$-64M	$-46M	$-48M	$69M	$-103M	$-7M
2024	$64M	$-47M	$-29M	$-51M	$13M	$-19M	$-7M
2023	$88M	$-134M	$-31M	$-54M	$34M	$-19M	$-7M
2022	$73M	$-55M	$-46M	$-46M	$27M	$-37M	$-7M
2021	$134M	$-79M	$12M	$-45M	$89M	$-19M	$-2M
2020	$127M	$-232M	$6M	$-40M	$87M	$-42M
2019	$76M	$29M	$-40M	$-30M	$46M	$-40M
2018	$129M	$-25M	$-24M	$-25M	$104M	$-15M
2017	$120M	$-32M	$-81M	$-37M	$83M	$-1M
2016	$80M	$-31M	$-48M	$-31M	$49M	$-2M
2015	$63M	$-39M	$-28M	$-29M	$34M	$-3M

Cash Flow Trends

A Piotroski F‑Score of 5 out of 9 places TriMas in the median range, indicating mixed signals on profitability, operating efficiency, and leverage improvements.
The Altman Z‑score of 1.91 falls within the gray zone (1.8–3.0), suggesting a non‑negligible probability of financial distress over the next two years if trends do not improve.
Operating cash flow covering 98% of net income (OCF/NI = 0.98) demonstrates that earnings are largely backed by cash generation, enhancing the credibility of reported profitability.

Balance Sheet & Cash Flow Health

TriMas Corporation (TRS) — FCF & Capital Returns

Free Cash Flow Statistics

Buyback & Dividend Trends

A Piotroski F‑Score of 5 out of 9 places TriMas in the median range, indicating mixed signals on profitability, operating efficiency, and leverage improvements.
The Altman Z‑score of 1.91 falls within the gray zone (1.8–3.0), suggesting a non‑negligible probability of financial distress over the next two years if trends do not improve.
Operating cash flow covering 98% of net income (OCF/NI = 0.98) demonstrates that earnings are largely backed by cash generation, enhancing the credibility of reported profitability.

Executive Insights & Key Takeaways

Key Takeaways

1Y Return

▲ +52.5%

vs S&P +28.9pp

Revenue 3Y CAGR

▼ -9.9%

5Y: -3.5%

Net Margin

18.6%

▲ 3Y ago: 7.5%

ROIC

1.5%

▼ 3Y ago: 7.2%

FCF Margin

10.7%

▲ 3Y ago: 3.0%

Piotroski

5/9

Moderate

TriMas delivered an exceptional 52.5% total return over the past year, outpacing the S&P 500 by nearly 29% while maintaining a modest beta of 0.57, indicating strong upside with limited market sensitivity. The company’s profitability remains solid, with an 18.6% net margin and a 17.0% ROE supported by low leverage (2.10x) and a healthy current ratio of 2.52, suggesting ample liquidity to fund operations. However, revenue growth has stalled, posting only 2.4% YoY growth and a negative three‑year CAGR of -9.9%, which pressures future earnings expansion despite the attractive free cash flow conversion of 10.7% margin. The balance sheet is relatively conservative—debt-to-equity at 0.72 and interest coverage at 0.8x—yet the low coverage ratio signals potential strain if earnings deteriorate. Overall, TriMas combines high short‑term returns with robust profitability but faces a growth headwind that investors must weigh against its defensive financial profile.

✅ Strengths

The stock’s 1‑year total return of 52.5% generated an excess return of +28.9% versus the S&P 500, reflecting strong price appreciation while the low beta (0.57) limits downside volatility, reinforcing a favorable risk‑adjusted profile (Sharpe 1.39).
TriMas’s net profit margin of 18.6% and ROE of 17.0% are well above industry averages, indicating efficient earnings generation from its asset base and supporting dividend sustainability.
A free cash flow margin of 10.7% combined with an OCF/NI ratio of 0.98 demonstrates that nearly all net income is converted to cash, providing flexibility for share repurchases or strategic acquisitions.

⚠️ Risks

Revenue is contracting, with a three‑year CAGR of -9.9% and only 2.4% YoY growth, which could erode earnings momentum if the decline continues despite current profitability.
Interest coverage stands at just 0.8x, meaning operating income barely covers interest obligations; any dip in earnings could force liquidity tightening or covenant breaches.
The Altman Z‑score of 1.9 places TriMas in the “gray” zone for credit risk, signaling heightened vulnerability to economic downturns that could impair its ability to service debt.

TRS

Related Reports

Visit finexus.net/reports for Valuation, Return & Risk, and other reports

Report written 2026-06-07 • Finexus

Disclaimer

This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.

The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.

Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.